Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study

BACKGROUND: Biosimilar drugs have broadened the treatment options in assisted reproductive technology (ART). Real-world data comparing clinical outcomes of originator follitropin alfa (Gonal-f(®)) with its biosimilars are required to enrich the body of evidence for clinical decision-making on choice...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Nayana Hitesh, Patel, Niket H., Patel, Molina Niket, Bhadarka, Harsha K., Vyas, Kairavi Sunilkumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404022/
https://www.ncbi.nlm.nih.gov/pubmed/37547084
http://dx.doi.org/10.4103/jhrs.jhrs_37_23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404022/
https://www.ncbi.nlm.nih.gov/pubmed/37547084
http://dx.doi.org/10.4103/jhrs.jhrs_37_23

Ejemplares similares